OHSU in the news

SARS-CoV-2 and immunology: antibody developments

Drug Target Review February 15, 2021
While discussing an OHSU study that found antibodies generated by SARS-CoV-2 react to other strains of coronavirus and vice-versa, Fikadu Tafesse, Ph.D., says “I do not think there is any one size-fits-all vaccine. Although the vaccines coming out now may break the momentum of the virus and end the pandemic, they may not be the end game.”

Societies agree on eye safety for HCQ

MedPage Today February 11, 2021
In a story about four medical societies issuing a statement about the safe use of hydroxychloroquine to treat ocular toxicity, James Rosenbaum, M.D., says “The goal of retinal screening is to safely maintain the use of this valuable medication for as long as possible for patients with rheumatic diseases, including cutaneous manifestations of rheumatic diseases.”
See more stories